ÂÜÀòÂÒÂ×

Tuulikki Lindmark is a seasoned professional in pharmaceutical development with extensive experience spanning various positions since 1998. Currently serving as Consultant and Owner/CEO at TuuLifeScience AB, and Head of CMC and Pharm. Dev at Attgeno since November 2019, Tuulikki has also held roles such as Pharmaceutical Specialist at Disruptive Pharma AB and Director of Pharma R&D at SwedenBIO. Tuulikki's expertise encompasses solid oral dosage form development, outsourcing, and CMC activities, complemented by a robust academic background with a PhD in Pharmaceutics and an MSc in Pharmacy from Uppsala University. Previous positions include leadership roles at Biovitrum and Creative Antibiotics AB, along with board membership at Sveriges Farmaceuter.